Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
Canada
COVID-19
NITAG documentation
2021
Americas
Clear all
Type of publications
NITAG documentation
(15)
Systematic reviews (SYSVAC)
(1)
Topics
Recommendation
(15)
Available to download in languages
English (EN)
(15)
French (FR)
(4)
Regions
Americas
(15)
Europe
(8)
Countries
Canada
(15)
Argentina
(1)
Bolivia
(2)
Chile
(9)
United States of America
(34)
Diseases
COVID-19
(15)
Vaccine topics
Target population
Adults
(1)
Methodological quality (AMSTAR 2)
Publication date
2021
(15)
2024
(1)
2023
(5)
2022
(13)
2020
(4)
15 results found
2021
Enhancing COVID-19 Vaccine Acceptance in Canada
2021
∙
NACI
Extended dose intervals for COVID-19 vaccines to optimize early vaccine rollout and population protection in Canada in the context of limited vaccine supply - 7 April, 2021
2021
∙
NACI
Guidance on booster COVID-19 vaccine doses in Canada – Update December 3, 2021
2021
∙
NACI, Public Health Agency of Canada
Guidance on the prioritization of key populations for COVID-19 immunization
2021
∙
NACI
Interim guidance on booster COVID-19 vaccine doses in Canada
2021
∙
NACI
NACI has updated its recommendations on the use of COVID-19 vaccines to include advice on the use of the Janssen COVID-19 vaccine - May 3, 2021
2021
∙
NACI
NACI issues updated recommendation on the use of mRNA COVID-19 vaccines in adolescents 12 to 17 years of age - 27 August, 2021
2021
∙
NACI
NACI rapid response: Additional dose of COVID-19 vaccine in immunocompromised individuals following 1- or 2- dose primary series - 10 September, 2021
2021
∙
NACI
NACI rapid response: Extended dose intervals for COVID-19 vaccines to optimize early vaccine rollout and population protection in Canada
2021
∙
NACI
NACI Rapid Response: Interchangeability of Authorized COVID-19 Vaccines - 01 June 2021
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register